AN2 Therapeutics, Inc.

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Correspondence with the SEC

Letter from the SEC

Other Events

Registration statement under Securities Act of 1933

Rule 506(b) provides a "safer harbor" for a private offering

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Financial Statements and Exhibits

Unregistered Sales of Equity Securities

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Financial Statements and Exhibits

Regulation FD Disclosure

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

1.01,3.03,5.03,9.01

Registration of Securities on Exchange

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

No description available

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Correspondence with the SEC

Correspondence with the SEC

No description available

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)

Trenor Cameron C. III

Readnour Robin Shane

Readnour Robin Shane

Williams Sarah Joanne

FitzPatrick Margaret M

Trenor Cameron C. III

Readnour Robin Shane

Readnour Robin Shane

Zakrzewski Joseph S

Martin Patricia A.

Aziz Kabeer

Marks Gilbert Lynn

Eizen Joshua M

Williams Sarah Joanne

Aziz Kabeer

Martin Patricia A.

Marks Gilbert Lynn

Spigelman Melvin K

Easom Eric